Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Sarepta Therapeutics (SRPT) SEC Filings & 10K Form

Sarepta Therapeutics logo
$18.34 +0.27 (+1.49%)
Closing price 04:00 PM Eastern
Extended Trading
$18.36 +0.02 (+0.08%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Sarepta Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/21/2025
6:07 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2025
4:28 PM		ARROWHEAD PHARMACEUTICALS, INC. (Subject)
Sarepta Therapeutics (Filed by)
Form SCHEDULE 13D/A
08/13/2025
7:55 PM		ARROWHEAD PHARMACEUTICALS, INC. (Subject)
Sarepta Therapeutics (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2025
11:49 AM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SCHEDULE 13G/A
08/06/2025
7:02 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
7:03 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
7:01 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2025
7:00 PM		Sarepta Therapeutics (Issuer)
Wong Ryan Ho-Yan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2025
7:10 PM		Sarepta Therapeutics (Issuer)
Wong Ryan Ho-Yan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
7:14 PM		D. E. SHAW & CO, L.P. (Filed by)
Sarepta Therapeutics (Subject)
Form SCHEDULE 13G/A
07/21/2025
6:30 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2025
3:11 PM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
3:30 PM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
6:32 AM		Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:00 AM		Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
3:15 PM		Sarepta Therapeutics (Filer)
Form ARS
03/13/2025
7:00 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:33 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.tc pixel

Learn these 4 simple steps and protect your savings before it’s too late.
03/04/2025
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:05 PM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
12:32 PM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:38 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:00 PM		Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
7:30 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
11:25 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:00 PM		Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:06 PM		Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
7:00 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:18 PM		Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:15 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:00 PM		Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/26/2024
6:17 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
7:00 PM		Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:40 AM		JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
11/13/2024
9:27 AM		Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
09/16/2024
7:00 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2024
7:05 PM		Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:51 AM		Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:00 PM		BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:00 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
4:03 PM		Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SRPT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...
The Oxford Club | Sponsoredtc pixel
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Trump’s national nightmare is here
AI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...
Porter & Company | Sponsoredtc pixel